Antipsychotic Drugs: A New Risk Factor for Osteoporosis in Young Women With Schizophrenia?
Abstract
Schizophrenic illness is associated with high rates of osteoporosis, the etiology of which remains obscure, but which may be at least partly explained by the prolactin-raising properties of antipsychotic medication. Conventional antipsychotics all cause hyperprolactinemia, whereas a limited number of atypical antipsychotic drugs do not. To investigate this further, we designed a cross-sectional comparison study between groups taking either prolactin-raising or prolactin-sparing antipsychotic medication. Participants were required to be premenopausal women with a diagnosis of schizophrenia, and to have received exclusively either prolactin-raising (n = 26), or olanzapine (n = 12) antipsychotic medication. Half of the subjects in the prolactin-raising group were being treated with conventional (n = 13), and half with newer "atypical," antipsychotic drugs (n = 13). Subjects had lumbar spine and hip bone mineral density (BMD) evaluated by a dual-energy x-ray absorptiometer (DEXA) scan. A blood sample was taken to measure prolactin and sex hormone axis measures. The results demonstrated that the group taking prolactin-raising medication had higher rates of bone pathology, compared with the olanzapine group. High prolactin levels were related to measures of hypogonadism and low BMD values. Within the prolactin-raising group, those taking newer atypical compounds had higher levels of prolactin, lower levels of sex hormones, and lower BMD values than the group taking conventional antipsychotic medication. These findings suggest that the high rates of osteoporosis associated with schizophrenia may result from hypogonadism secondary to antipsychotic-induced hyperprolactinemia, and that the prolactin-raising profile of antipsychotic drugs should be considered when choosing an antipsychotic drug.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some studies found a relationship between the use of prolactin-raising medication and low bone mineral density in patients with chronic schizophrenia, while others failed to find a relationship between prolactin, antipsychotics and osteoporosis.
“Some studies (490-493) found a relationship between the use of prolactin-raising medication and low BMD in patients with chronic schizophrenia, while others (474,489,494-498) failed to find a relationship between prolactin, AP and osteoporosis.”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [491]
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090 · see citing works
Kapur, S., Zipursky, R., Jones, C., Remington, G., & Houle, S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.514 · Cited by 1,090 · see citing works
Mechanisms of Osteoporosis in Adult and Adolescent Women with Anorexia Nervosa*
Biller, B. M. K., SAXE, V. C., Herzog, D. B., Rosenthal, D. I., HOLZMAN, S., & Klibanski, A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-3-548 · Cited by 417 · see citing works
Kinon, B. J., Gilmore, J. A., Liu, H., & Halbreich, U. M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00127-0 · Cited by 350 · see citing works
Sexual dysfunction in patients taking conventional antipsychotic medication
Smith, S., O'Keane, V., & Murray, R. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.181.1.49 · Cited by 256 · see citing works
Self-citationElevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects
Halbreich, U. M., Kinon, B. J., Gilmore, J. A., & Kahn, L. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00112-9 · Cited by 250 · see citing works
Metabolic Syndrome in Patients With Schizophrenia
Heiskanen, T. H., NISKANEN, L. K., Lyytikäinen, R., Saarinen, P., & Hintikka, J. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0513 · Cited by 229 · see citing works
Meaney, A. M., Smith, S., Howes, O. D., O'Brien, M., Murray, R. M., & O'Keane, V. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.503 · Cited by 217 · see citing works
Self-citationThe Effects of Antipsychotic-Induced Hyperprolactinaemia on the Hypothalamic-Pituitary-Gonadal Axis
Smith, S. M., Wheeler, M. J., Murray, R. M., & O’Keane, V. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00002 · Cited by 202 · see citing works
Self-citationDecreased Bone Mineral Density in Medicated Psychiatric Patients
Halbreich, U. M., Rojansky, N., Palter, S. F., Hreshchyshyn, M. M., Kreeger, J., Bakhai, Y., & Rosan, R. C. (1995) · Psychosomatic Medicine · doi:10.1097/00006842-199509000-00011 · Cited by 193 · see citing works
The Association of Bone Mineral Density and Depression in an Older Population
Robbins, J., Hirsch, C., Whitmer, R., Cauley, J., Harris, T., & Study, F. T. C. H. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49149.x · Cited by 180 · see citing works
Bone Density in Amenorrheic Women with and without Hyperprolactinemia*
Schlechte, J., Sherman, B. M., & Martin, R. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1120 · Cited by 170 · see citing works
Low lumbar bone mineral density in patients with major depression
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.11.1691 · Cited by 165 · see citing works
Antipsychotics: impact on prolactin levels
Goodnick, P. J., Santana, O., & Rodriguez, L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.10.1381 · Cited by 124 · see citing works
Becker, D., Liver, O., Mester, R., Rapoport, M., Weizman, A., & Weiss, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0704 · Cited by 107 · see citing works
Bone Disorder in Men with Chronic Alcoholism: A Reversible Disease?
Lindholm, J., Steiniche, T., RASMUSSEN, E., Thamsborg, G., NIELSEN, I. O., Brockstedt-Rasmussen, H., Storm, T., Hyldstrup, L. H., & SCHOU, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-118 · Cited by 101 · see citing works
Schlechte, J., Walkner, L. M., & Kathol, M. H. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1517357 · Cited by 88 · see citing works
Adami, S., Zamberlan, N., Castello, R., Tosi, F., Gatti, D., & Moghetti, P. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3691182.x · Cited by 82 · see citing works
Abraham, G., Paing, W. W., Kaminski, J., Joseph, A., Kohegyi, E., & Josiassen, R. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1618 · Cited by 82 · see citing works
Hyperprolactinaemia caused by antipsychotic drugs
Wieck, A. (2002) · BMJ · doi:10.1136/bmj.324.7332.250 · Cited by 76 · see citing works
Dual-energy X-ray absorptiometry in clinical practice
Theodorou, D. J., & Theodorou, S. J. (2002) · Clinical Imaging · doi:10.1016/s0899-7071(01)00356-4 · Cited by 56 · see citing works
Stiegler, C., Leb, G., Kleinert, R., Warnkross, H., Ramschak-Schwarzer, S., Lipp, R. W., Clarici, G., Krejs, G. J., & Dobnig, H. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100512 · Cited by 50 · see citing works
CLASSICAL AND ATYPICAL NEUROLEPTICS, AND BONE MINERAL DENSITY, IN PATIENTS WITH SCHIZOPHRENIA
BILICI, M., CAKIRBAY, H., GULER, M., TOSUN, M., ULGEN, M., & TAN, U. (2002) · International Journal of Neuroscience · doi:10.1080/00207450290025833 · Cited by 48 · see citing works
Osteoporosis and Depression: Shedding More Light Upon a Complex Relationship
Lyles, K. W. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49162.x · Cited by 33 · see citing works
Yoshimura, N., Kasamatsu, T., Sakata, K., Hashimoto, T., & Cooper, C. C. (2002) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740200044 · Cited by 26 · see citing works
Relative effects of prolactin excess and estrogen deficiency on bone in rats
Adler, R. A., Evani, R., Mansouri, A., et al. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90054-3 · Cited by 25 · see citing works
Tay, C. C. K., Glasier, A. F., Illingworth, P. J., et al. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02415.x · Cited by 21 · see citing works
Osteoporosis demonstrated by dual energy X-ray absorptiometry in chronic schizophrenic patients
Abraham, G., Friedman, R. H., & Verghese, C. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(96)82517-0 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488 · see citing works
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988 · see citing works
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633 · see citing works
Risk of hip fracture in patients with a history of schizophrenia
Howard, L., Kirkwood, G., & Leese, M. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.023671 · Cited by 158 · see citing works
Byerly, M., Suppes, T., Tran, Q.-V., & Baker, R. A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4e5 · Cited by 153 · see citing works
Joffe, H., Cohen, L. S., Suppes, T., McLaughlin, W. L., Lavori, P., Adams, J. M., Hwang, C. H., Hall, J. E., & Sachs, G. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.017 · Cited by 134 · see citing works
Abi-Dargham, A., Kegeles, L. S., Zea-Ponce, Y., Mawlawi, O., Martinez, D., Mitropoulou, V., O'Flynn, K., Koenigsberg, H. W., Van Heertum, R., Cooper, T., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.018 · Cited by 128 · see citing works
O'Keane, V. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088439 · Cited by 126 · see citing works
Self-citationA meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia
Stubbs, B., De Hert, M., Sepehry, A. A., Correll, C. U., Mitchell, A. J., Soundy, A., Detraux, J., & Vancampfort, D. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12313 · Cited by 92 · see citing works
Meaney, A. M., & O'Keane, V. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.013 · Cited by 92 · see citing works
Self-citationKelly, D. L., & Conley, R. R. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.08.010 · Cited by 88 · see citing works
Montejo, Á. L., Arango, C., Bernardo, M., Carrasco, J. L., Crespo-Facorro, B., Cruz, J. J., del Pino, J., García Escudero, M. A., García Rizo, C., González-Pinto, A., et al. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2015.11.003 · Cited by 55 · see citing works
High bone turnover but normal bone mineral density in women suffering from schizophrenia
Bergemann, N., Parzer, P., Mundt, C., & Auler, B. (2008) · Psychological Medicine · doi:10.1017/s003329170800319x · Cited by 37 · see citing works
Tanda, G., Valentini, V., De Luca, M. A., Perra, V., Serra, G. P., & Di Chiara, G. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3780-2 · Cited by 33 · see citing works
Javaid, M. K., & Holt, R. I. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107087955 · Cited by 28 · see citing works
- Authors
- O'Keane, V., & Meaney, A. M.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2005-02
- Volume
- 25
- Issue
- 1
- Pages
- 26-31
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2012720659
- Cited by
- 307
- References
- 28
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 7 · 2020: 9 · 2019: 6 · 2018: 9 · 2017: 4 · 2016: 22 · 2015: 18 · 2014: 22 · 2013: 23 · 2012: 27
- FWCI
- 16.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- schizophrenia, osteoporosis, antipsychotic drugs, hyperprolactinemia, atypical antipsychotics, olanzapine, bone mineral density, hypogonadism, sex hormones, lumbar spine, hip bone density
- MeSH terms
- Adult, Alcohol Drinking, Bone Diseases, Metabolic, Female, Humans, Hyperprolactinemia, Hypogonadism, Menstruation Disturbances, Osteoporosis, Prolactin, Psychiatric Status Rating Scales, Regression Analysis, Risk Factors, Schizophrenia, Gonadal Steroid Hormones, Smoking, Antipsychotic Agents, Absorptiometry, Photon, Bone Density, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
